Best of BMB 2022
For the second consecutive year, the ASBMB Today team is proud to present a list of exciting developments in biochemistry and molecular biology. This year’s nominees, chosen from ASBMB member nominations and significant science headlines throughout the year, illuminate several trends.
The revolution in structural biology launched by a new generation of powerful computational models has continued to spread, bringing multiprotein structural complexes into reach. Meanwhile, researchers are finding new ways to understand more flexible proteins’ structures, exploring ensemble modeling and evolutionary constraints on intrinsically disordered regions.
High-throughput studies continue to flourish. Single-cell transcriptomics and spatial transcriptomics can yield powerful insights when wielded in combination. Ribosome profiling and metabolomics are uncovering new insights into how cells regulate basic homeostatic challenges and how organisms respond to stimuli.
Other studies show how drug development is being influenced by computational tools that aim to save time in the lab, from peptide design to enzymatic activity prediction.
Still, there is sometimes no substitute for in-depth investigation of a single target, as revealed by one study that dug in to find that an enzyme’s true function is nothing like what was annotated — and that it carries out a reaction never before observed in nature.
We applaud the authors of this year’s Best of BMB nominees and look forward to a new year filled with even more exciting discoveries.
Best of BMB 2022
Read the entire series.
Evolutionary constraints on disordered proteins
“There’s evidence that there must be conservation of function — so how does this happen, if the sequence changes so much?”
Giant, intricate structures
In a “triumph of experimental structural biology,” multiple teams tackle the nuclear pore complex.
Cataloging itty-bitty proteins in large numbers
Ribosome profiling has identified thousands of short protein-coding genes, many in unexpected parts of the genome. Research suggests some play important regulatory roles.
Predicting PROTAC properties
Proteolysis-targeting chimeras bring together a drug target protein and a ubiquitin ligase to remove the target from the cell. But sometimes the process stalls out.
A macrocyclic lipid and the enzyme that makes it
One of many adaptations that archaea make to survive their superheated, high-pressure and frequently acidic deep-sea environments is remodeling their cellular membranes.
Advancing structural biology to blazing speed
This year AlphaFold, algorithm, written by Alphabet subsidiary DeepMind, made 200 million protein structure predictions, roughly 25 terabytes of data.
Increasingly versatile peptide drugs for diabetes
Best of BMB 2022: This year, the FDA approved the first peptide drug that works as a bifunctional agonist; tirzepatide both causes weight loss and improves cardiometabolic and glycemic outcomes in diabetic patients. Meanwhile, labs are looking.
An exercise molecule?
Lac-Phe, the small molecule that increases in concentration most dramatically after a workout, forms through enzymatic conjugation of lactate with the amino acid phenylalanine.
Spatial transcriptomics sharpens distinctions between brains
Researchers can microdissect tiny portions of tissues for RNA sequencing, capture nucleic acids in a defined pattern before single-cell sequencing, or hybridize fluorescent probes to RNA and image it in thin tissue sections.
Enjoy reading ASBMB Today?
Become a member to receive the print edition monthly and the digital edition weekly.Learn more
Get the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
"As you sift through the applications ... look for signs of altruism, vision and an investment mentality rather than the extent of administrative experience and managerial acumen," Pete Kennelly writes.